We’ve just had 4 significant pieces of news.
1. Highly significant in-human OSA results
2. NASDAQ listing
3. Acquisition of APIRx
4. Loyalty option entitlement
Major clinical results are a long and exhaustive process. Do you think the board and medical team just knock these up in Joel’s garage?
These guys have done an outstanding job in a very quick period of time. And the share price performance has been phenomenal.
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-13225
-
-
- There are more pages in this discussion • 6,800 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)